PBA

Paradigm Biocapital Advisors Portfolio holdings

AUM $2.34B
1-Year Est. Return 13.3%
This Quarter Est. Return
1 Year Est. Return
+13.3%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.17B
AUM Growth
-$702M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
33
New
Increased
Reduced
Closed

Top Buys

1
+$70.7M
2
+$34.5M
3
+$34.4M
4
MTSR
Metsera Inc
MTSR
+$32.4M
5
COGT icon
Cogent Biosciences
COGT
+$24.2M

Top Sells

1
+$250M
2
+$60.8M
3
+$44.7M
4
PLRX icon
Pliant Therapeutics
PLRX
+$42.1M
5
TECX
Tectonic Therapeutic
TECX
+$22.4M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCUL icon
26
Ocular Therapeutix
OCUL
$2.51B
$9.63M 0.44%
+1,314,018
IMTX icon
27
Immatics
IMTX
$1.2B
$8.6M 0.39%
1,907,108
-3,507,301
ORKA
28
Oruka Therapeutics
ORKA
$1.33B
– –
-819,660
AGIO icon
29
Agios Pharmaceuticals
AGIO
$2.46B
– –
-276,439
PLRX icon
30
Pliant Therapeutics
PLRX
$96.4M
– –
-3,197,050
SRRK icon
31
Scholar Rock
SRRK
$2.69B
– –
-400,000
VERA icon
32
Vera Therapeutics
VERA
$1.99B
– –
-1,437,339
TECX
33
Tectonic Therapeutic
TECX
$323M
– –
-485,105
1
2